^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Pancreatic Cancer |
| Drug: | temozolomide (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
05/23/2022
Excerpt:
Pancreatic Neuroendocrine Tumors (Well-Differentiated Grade 1/2)...Preferred Regimens...Temozolomide + capecitabine...
Secondary therapy:
capecitabine
